Home

atteindre Lautre jour Vous êtes les bienvenus kawasaki disease criteria 2017 Estimé trou de soufflage Expiré

Frontiers | Neurological manifestations of Kawasaki disease and multisystem  inflammatory syndrome in children associated with COVID-19: A comparison of  two different clinical entities
Frontiers | Neurological manifestations of Kawasaki disease and multisystem inflammatory syndrome in children associated with COVID-19: A comparison of two different clinical entities

Primary care approach to Kawasaki disease | SMJ
Primary care approach to Kawasaki disease | SMJ

Kawasaki disease
Kawasaki disease

Clinical and Experimental Pediatrics
Clinical and Experimental Pediatrics

Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A  Scientific Statement for Health Professionals From the Ame
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the Ame

Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A  Scientific Statement for Health Professionals From the American Heart  Association | Circulation
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation

Kawasaki Disease - how to prevent coronary artery lesions | Encyclopedia  MDPI
Kawasaki Disease - how to prevent coronary artery lesions | Encyclopedia MDPI

Primary care approach to Kawasaki disease | SMJ
Primary care approach to Kawasaki disease | SMJ

Frontiers | Kawasaki Disease
Frontiers | Kawasaki Disease

Conference Notes 11-15-2017 — ACMC EM
Conference Notes 11-15-2017 — ACMC EM

An Overview of Kawasaki Disease
An Overview of Kawasaki Disease

Effects of immunoglobulin plus prednisolone in reducing coronary artery  lesions in patients with Kawasaki disease: study protocol for a phase III  multicenter, open-label, blinded-endpoints randomized controlled trial |  Trials | Full Text
Effects of immunoglobulin plus prednisolone in reducing coronary artery lesions in patients with Kawasaki disease: study protocol for a phase III multicenter, open-label, blinded-endpoints randomized controlled trial | Trials | Full Text

Factors affecting the duration of coronary artery lesions in patients with  the Kawasaki disease: a retrospective cohort study | Pediatric Rheumatology  | Full Text
Factors affecting the duration of coronary artery lesions in patients with the Kawasaki disease: a retrospective cohort study | Pediatric Rheumatology | Full Text

Diagnostic criteria for Kawasaki Disease: fever must be present, with 4...  | Download Table
Diagnostic criteria for Kawasaki Disease: fever must be present, with 4... | Download Table

Kawasaki Disease Shock Syndrome: A Single Center Cohort - ACR Meeting  Abstracts
Kawasaki Disease Shock Syndrome: A Single Center Cohort - ACR Meeting Abstracts

Rheumato | Free Full-Text | Kawasaki Disease: Management Challenges during  COVID-19 Pandemic with an Upsurge in Multisystem Inflammatory Syndrome in  Children
Rheumato | Free Full-Text | Kawasaki Disease: Management Challenges during COVID-19 Pandemic with an Upsurge in Multisystem Inflammatory Syndrome in Children

It is important to be aware that... - Kawasaki Disease Canada | Facebook
It is important to be aware that... - Kawasaki Disease Canada | Facebook

2021 Update on the Clinical Management and Diagnosis of Kawasaki Disease |  SpringerLink
2021 Update on the Clinical Management and Diagnosis of Kawasaki Disease | SpringerLink

Preterm birth and Kawasaki disease: a nationwide Japanese population-based  study | Pediatric Research
Preterm birth and Kawasaki disease: a nationwide Japanese population-based study | Pediatric Research

Intravenous Immunoglobulin for the Treatment of Kawasaki Disease |  Pediatric Annals
Intravenous Immunoglobulin for the Treatment of Kawasaki Disease | Pediatric Annals

An Algorithmic Approach to Multisystem Inflammatory Syndrome in Children  with COVID-19: Tehran Children's Medical Center Protocol | Iranian Journal  of Pediatrics | Full Text
An Algorithmic Approach to Multisystem Inflammatory Syndrome in Children with COVID-19: Tehran Children's Medical Center Protocol | Iranian Journal of Pediatrics | Full Text

Pharmacologic interventions for Kawasaki disease in children: A network  meta-analysis of 56 randomized controlled trials - eBioMedicine
Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials - eBioMedicine

An Overview of Kawasaki Disease
An Overview of Kawasaki Disease